Senior insider sale
Chief Technical Officer at RHYTHM PHARMACEUTICALS, INC. — senior position signals high conviction
$597.3K
5.08K shares
What this filing means
SHULMAN JOSEPH plans to sell 5.08K shares of RHYTHM PHARMACEUTICALS, INC. valued at approximately $597.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/13/2026ACC: 0001950047-26-008094
Officer· Chief Technical Officer
Since Feb 2022
5.08K
Shares to sell
$597.3K
Approx. market value
5.08K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Exercise of Stock Options
Cash
8/13/2026
2.02KRestricted Stock Units
N/A
2/1/2025
3.06KTotal acquired5.08K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/13/2026 | Exercise of Stock Options Cash | 2.02K | — |
2/1/2025 | Restricted Stock Units N/A | 3.06K | — |
| Total | 5.08K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
5.08K
Market value
$597.3K
8/13/2026
Total
Units
5.08K
Value
$597.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/13/2026 | 5.08K | $597.3K | NASDAQ | Planned |
| Total | 5.08K | $597.3K | ||